Hypothalamic peptides in human brain diseases

Trends in Endocrinology and Metabolism

Volumn 10, Issue 6, 1999, Pages 236-244

  Swaab, Dick F ^a  

^a Amsterdam University Medical Center   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; GONADORELIN; HYDROCORTISONE; MESSENGER RNA; MORPHINE; NEUROPEPTIDE; OXYTOCIN; THIOPENTAL; VASOPRESSIN; NEUROHORMONE; NEUROPHYSIN;

ALZHEIMER DISEASE; BRAIN DISEASE; DEPRESSION; DIABETES INSIPIDUS; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KALLMANN SYNDROME; MENTAL DISEASE; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENTIATION; SUPRACHIASMATIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; BIOLOGICAL RHYTHM; BRAIN DEATH; CLIMACTERIUM; INFUNDIBULUM; NEUROENDOCRINE DISEASE; NEUROSECRETORY CELL; SEXUAL ORIENTATION; STRIA TERMINALIS; SUPRAOPTIC NUCLEUS;

EID: 0033176488     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00158-7     Document Type: Review

References (50)

1. Honnebier W.J., Swaab D.F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J. Obstet. Gynaecol. Br. Commonwlth. 7:1973;577-588.
2. Swaab D.F., Purba J.S., Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80:1995;573-579.
3. Willnow S.et al. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome) - evaluation and follow up of 18 patients. Eur. J. Pediatr. 155:1996;179-184.
4. Maghnie M.et al. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J. Clin. Endocrinol. Metab. 73:1991;79-83.
5. Ishunina, T.A., Salehi, A., Hofman, M.A. and Swaab, D.F. Activity of vasopressinergic neurones of the human supraoptic nucleus is age-sex-dependent. J. Neuroendocrinol. 11, 251-258.
6. Swaab D.F., Hofman M.A. An enlarged suprachiasmatic nucleus in homosexual men. Brain Res. 537:1990;141-148.
7. Swaab D.F., Hofman M.A. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci. 18:1995;264-270.
8. LeVay S. A difference in hypothalamic structure between heterosexual and homosexual men. Science. 253:1991;1034-1037.
9. Zhou J.N., Hofman M.A., Gooren L.J.G., Swaab D.F. A sex difference in the human brain and its relation to transsexuality. Nature. 378:1995;68-70.
10. Hansen L.K., Rittig S., Robertson G.L. Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol. Metab. 8:1997;363-372.
11. Scherbaum, W.A. (1992) Autoimmune hypothalamic diabetes insipidus ('autoimmune hypothalamitis'). In Progress in Brain Research. The Human Hypothalamus in Health and Disease (Vol. 93) (Swaab, D.F., Hofman, M.A., Mirmiran, M., Ravid, R. and Van Leeuwen, F.W., eds), pp 283-293, Elsevier.
12. Gabreëls B.A.Th.F.et al. The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J. Clin. Endocrinol. Metab. 83:1998;4026-4033.
13. Swaab, D.F. (1998) The human hypothalamo-neurohypophysial system in health and disease. In Progress in Brain Research. Advances in Brain Vasopressin (Vol. 119) (Urban, I.J.A., Burbach, J.P.H. and De Wied, D., eds), pp 577-618, Elsevier.
14. Swaab D.F., Raadsheer F.C., Endert E., Hofman M.A., Kamphorst W., Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid J. Neuroendocrinol. 6:1994;681-687.
15. Lamberts S.W.J., Bruining H.A., De Jong F.H. Corticosteroid therapy in severe illness. Drug Ther. 337:1997;1285-1292.
16. Gramm H-J.et al. Acute endocrine failure after brain death. Transplantation. 54:1992;851-857.
17. Iwai A., Sakano T., Uenishi M., Sugimoto H., Yoshioka T., Sugimoto T. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation. 48:1989;613-617.
18. Truog R.D. Is it time to abandon brain death? Hastings Center Report Jan-Feb. 27:1997;29-37.
19. Rance N.E. Hormonal influences on morphology and neuropeptide gene expression in the infundibular nucleus of post-menopausal women. Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., Van Leeuwen F.W. The Human Hypothalamus in Health and Disease. Progress in Brain Research. 93:1992;221-236 Elsevier.
20. Rance N.E., Uswandi S.V. Gonadotropin-releasing hormone gene expression is increased in the medial basal hypothalamus of postmenopausal women. J. Clin. Endocrinol. Metab. 81:1996;3540-3546.
21. Hosono T.et al. Effect of gonadotropin releasing hormone on thermoregulatory vasomotor activity in ovariectomized female rats. Brain Res. 754:1997;88-94.
22. Schultz C., Braak H., Braak E. A sex difference in neurodegeneration of the human hypothalamus. Neurosci. Lett. 212:1996;103-106.
23. Swaab D.F. Brain aging and Alzheimer's disease: 'wear and tear' versus 'use it or lose it'. Neurobiol. Aging. 12:1991;317-324.
24. Schwanzel-Fukuda M., Crossin K.L., Pfaff D.W., Bouloux P.M.G., Hardelin J-P., Petit C. Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J. Comp. Neurol. 366:1996;547-557.
25. Fliers E., Guldenaar S.E.F., Wiersinga W.M., Swaab D.F. Hypothalamic thyrotropin-releasing hormone (TRH) gene expression in patients with nonthyroidal illness. J. Clin. Endocrinol. Metab. 82:1997;4032-4036.
26. Hofman M.A., Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651:1994;134-142.
27. Hofman M.A., Swaab D.F. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol. Aging. 16:1995;965-971.
28. Dai J., Swaab D.F., Van der Vliet J., Buijs R.M. Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain. J. Comp. Neurol. 400:1998;87-102.
29. Swaab, D.F. Biological rhythms in health and disease: the suprachiasmatic nucleus and the autonomic nervous system. In Handbook of Clinical Neurology. The Autonomic Nervous System (Part I) (Vinken, P.J. & Bruyn, G.W., eds) (in press).
30. Raadsheer F.C., Hoogendijk W.J.G., Stam F.C., Tilders F.J.H., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
31. Raadsheer F.C., Van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J.G., Tilders F.J.H., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry. 152:1995;1372-1376.
32. Holsboer F., Spengler D., Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., Van Leeuwen F.W. The Human Hypothalamus in Health and Disease. Progress in Brain Research. 93:1992;385-417 Elsevier.
33. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiat. 1:1996;336-342.
34. Purba J.S., Hoogendijk W.J.G., Hofman M.A., Swaab D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychol. 53:1996;137-143.
35. Van Londen L.et al. Plasma levels of arginine vasopressin elevated in a subgroup of patients with major depression. Neuropsychopharmacology. 17:1997;284-292.
36. Inder W.J.et al. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol. Psychiatry. 42:1997;744-747.
37. Van den Hoofdakker R.H. Chronobiological theories of nonseasonal affective disorders and their implications for treatment. J. Biol. Rhythms. 9:1994;157-183.
38. Kalsbeek A., Buijs R.M., Van Heerikhuize J.J., Arts M., Van der Woude T.P. Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580:1992;62-67.
39. Wirz-Justice A. Biological rhythms in mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: the Fourth Generation of Progress. 1995;999-1017 Raven Press.
40. Kripke D.F. Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J. Affect. Disord. 49:1998;109-117.
41. Kirkegaard C., Faber J. The role of thyroid hormones in depression. Eur. J. Endocrinol. 138:1998;1-9.
42. Jackson I.M.D. The thyroid axis and depression. Thyroid 8:1998;951-956.
43. Marangell L.B.et al. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch. Gen. Psychiatry. 54:1997;214-222.
44. Henley W.N., Koehnle T.J. Thyroid hormones and the treatment of depression: an examination of basic hormonal actions in the mature mammalian brain. Synapse. 27:1997;36-44.
45. Blouin A.et al. Seasonal patterns of bulimia nervosa. Am. J. Psychiatry. 149:1992;73-81.
46. Lam R.W., Goldner E.M., Solyom L., Remick R.A. A controlled study of light therapy for bulimia nervosa. Am. J. Psychiatry. 151:1994;744-750.
47. Swaab, D.F. (1997) Neurobiology and neuropathology of the human hypothalamus. In Handbook of Chemical Neuroanatomy. The Primate Nervous System (Part I) (Vol. 13) (Bloom, F.E. and Hökfelt, T., eds), pp 39-137.
48. Victor M. Alcoholic dementia. Can. J. Neurol. Sci. 21:1994;88-99.
49. Kuzniecky R., Mountz J., Bebin M., Faught E., Gilliam F., Liu H-G. Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann. Neurol. 42:1997;60-67.
50. Flynn F.G., Cummings J.L., Tomiyasu U. Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrome. Behav. Neurol. 1:1988;49-58.